Accelerate to discover

Back to filter

Related topics

Download today your IsoPlexis e-book: understanding immune Cell Function In Cancer

IsoPlexis

Dec 1, 2021

Understanding complex immune-cancer interactions is critical to identifying therapeutic targets, devising novel avenues...

IsoPlexis technology: accelerating decisions in immunotherapy with predictive single-cell response

IsoPlexis

Nov 25, 2021

The IsoLight is a hub for comprehensive functional profiling of each cell type across a large assay menu of single-cell...

Extensive assessment of Cytokine production on the NovoCyte Penteon flow cytometer

Agilent technologies

Nov 23, 2021

Cytokines are small molecules essential for immune cell response to activation by pathogens, autoimmunity, or...

Jan 26, 2022

Discover the advanced Detector Technology in Agilent NovoCyte flow cytometers

Agilent technologies

Nov 8, 2021

This technical overview describes advancements in detector technology, and highlights examples where optimal signal...

Introducing isoLight system - Automated Cellular Proteomics hub

IsoPlexis

Nov 4, 2021

The IsoLight is a hub for comprehensive functional profiling of each cell type across a large assay menu of single-cell...

Jan 26, 2022

Introducing Cytek NEW 25-Color Immunoprofiling Assay & Kit!

Cytek Biosciences

Oct 25, 2021

To unleash the power of the Cytek full spectrum cytometry system, Cytek scientists designed and developed the 25-Color...

Show all topics (10)

Highly advanced preclinical optical/x-ray imaging system comprising five imaging modalities

Jan 2, 2016

Xtreme II, the most advanced preclinical Optical/X-ray imaging system, brings a new level of sensitivity, speed and versatility to preclinical imaging. Discover important biological mechanisms in disease, treatments and monitoring using five imaging modalities including bioluminescence, multispectral VIS- NIR fluorescence, unique direct radioisotopic imaging and Cherenkov radiation.  

Key Applications:

  • Tumor and stem cell tracking
  • Luminescence imaging of inflammation
  • Optical imaging of PET probes with Cherenkov radiation
  • Tracking and validating single or multimodal nanoparticles
  • Imaging and validating new probes and biomarker
  • Non-invasively image changes in signaling cascades
  • Discover how genetics, small molecules and therapeutics affect biochemical pathways
  • Quantify changes in bone and soft tissue phenotype
  • High throughput pharmacodynamic studies
Technical breakthrough
Application
Product news

Brand profile

Bruker Biospin

Bruker is a performace leader in preclinical imaging instrumentation. Bruker offers nine imaging modalities: PET, SPECT, CT, MRI, MPI, fluorescence, luminiscence, radioisotipic imaging and X-ray.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey